Skip to content

Clinical Assessment of Complementary Treatment with DanHong injection on Acute Myocardial Infarction: A Randomized, controlled, Multicenter Trial

Clinical Assessment of Complementary Treatment with DanHong injection on Acute Myocardial Infarction: A Randomized, controlled, Multicenter Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007240
Enrollment
Unknown
Registered
2015-09-23
Start date
2014-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

1:Standardized treatment in accordance with the acute myocardial infarction guide+0.9%NS 50ml
1:Standardized treatment in accordance with the acute myocardial infarction guide+Danhong injection40ml

Sponsors

Beijing Hospital of Traditional Chinese Medicine affiliated Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Patients conform to the acute myocardial infarction diagnostic criteria; 2. Aged 18 to 79 years old; 3. The patient and/or family members are willing to participate in this test, andagreed to sign a consent form.

Exclusion criteria

Exclusion criteria: 1. Serious liver or kidney dysfunction (ALT>Three times greater than normal Scr>221umol/); 2. Cancer; 3. Cerebral hemorrhage within six months; 4. Bleeding, trauma, or active peptic ulcer within one month; 5. During pregnancy, nursing mothers, or have a pregnancy plan; 6. Allergic to the test medication; 7. In other clinical researchers nearly three months; 8. 2 weeks using any of the same as this drug ingredients preparation.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiac events of 30 days;The effect of TCM symptoms;

Secondary

MeasureTime frame
Major adverse cardiac events of 1 year;The effect of angina pectoris symptom;The complications during hospitalization;

Countries

China

Contacts

Public ContactLiu Hongxu
lhx_@263.net+86 13501161583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026